CHAMPVA does not cover Zepbound when it is prescribed for weight loss. It does list Zepbound as covered for moderate to severe obstructive sleep apnea when a sleep study within the past 12 months verifies the condition, with prior authorization through OptumRx at 844-403-1029 [1]. If your sleep study is 3 years old, it falls outside that stated window. The next question is not whether you can reuse the old result. It is whether you need a current sleep study before asking OptumRx to review the request.
Does CHAMPVA cover Zepbound for sleep apnea or only for weight loss?
The answer turns on the documented use. CHAMPVA does not cover GLP-1 medications prescribed for weight loss [1]. That includes the weight loss use of Zepbound. Calling the request a sleep apnea request does not change the underlying facts. The condition must be moderate to severe obstructive sleep apnea, and that condition must be verified by a sleep study within the past 12 months [1].
That creates a specific coverage pathway, not a general Zepbound benefit. Your diagnosed sleep apnea matters, but the age of the verification matters too. A diagnosis alone does not answer the question if the supporting sleep study sits outside the 12-month window stated by CHAMPVA.
CHAMPVA is the Civilian Health and Medical Program of the Department of Veterans Affairs. It serves the spouse or widow or widower and children of an eligible veteran [1]. A CHAMPVA beneficiary follows CHAMPVA rules, not the rules that apply to the veteran's VA care or to a different military health plan.
The CHAMPVA GLP-1 coverage guide gives the wider picture. The short version for Zepbound is precise: weight loss use is not covered, while moderate to severe obstructive sleep apnea can use the listed pathway when the sleep study is current enough and OptumRx prior authorization is obtained [1].
What does the 12-month sleep study rule mean?
The CHAMPVA page says moderate to severe obstructive sleep apnea must be verified by a sleep study within the past 12 months for the Zepbound pathway [1]. The date is the practical checkpoint. You need to compare the date on your sleep study with the current date before deciding what to send for prior authorization.
If the sleep study is within the past 12 months, the documented recency condition is met on its face. That does not mean coverage is automatic. Zepbound still requires prior authorization through OptumRx, and the final benefit decision sits with the official program source [1].
If the sleep study is 3 years old, it is not within the past 12 months. The facts provided for this pathway do not list an exception for an older report. They also do not list a different form of proof that replaces the sleep study, so do not assume that a diagnosis date, an old clinical note, or a prescription alone satisfies the stated rule.
This is why the sleep study date deserves attention before the phone call. A prior authorization request built around a report outside the stated window may not establish the condition under the published pathway. The CHAMPVA coverage hub can help you compare this rule with the program's other GLP-1 indications, but Zepbound's sleep apnea requirement remains its own check [1].
What does OptumRx prior authorization add?
Prior authorization means the benefit manager reviews the request against the program's requirements before the medication is covered. CHAMPVA requires prior authorization for Zepbound, and requests go to OptumRx at 844-403-1029 [1].
The call should come after you identify the pathway you are asking about. For Zepbound, that means moderate to severe obstructive sleep apnea verified by a sleep study within the past 12 months [1]. If your report is 3 years old, the useful question is whether a current sleep study is needed before the request is submitted. The published facts do not provide a separate OptumRx checklist, so avoid filling gaps with assumptions about other records or thresholds.
Keep the purpose of the request clear. CHAMPVA does not cover Zepbound for weight loss [1]. A request based only on weight loss does not become eligible because obstructive sleep apnea is also part of your health history. The covered indication described by CHAMPVA is moderate to severe obstructive sleep apnea, verified through the stated sleep study window [1].
The final call is still OptumRx's review under CHAMPVA's rules. The official CHAMPVA program page remains the source to check if the page or instructions change.
Is CHAMPVA the same as TRICARE for Zepbound?
No. CHAMPVA and TRICARE are different federal benefit programs, so a TRICARE answer does not decide a CHAMPVA request. CHAMPVA's published rule is the one that matters for a CHAMPVA beneficiary, including its separate Zepbound pathway for moderate to severe obstructive sleep apnea verified by a sleep study within the past 12 months [1].
TRICARE has its own weight loss coverage rules. As of August 31, 2025, TRICARE For Life and direct-care-only beneficiaries, and NATO or Partnership for Peace members, lost weight loss drug coverage and their approved prior authorizations are no longer valid, while TRICARE Prime and TRICARE Select, plus the premium-based plans listed by the program, keep coverage behind prior authorization [2].
That split is relevant only as a warning against mixing benefit rules. If your card says CHAMPVA, use the CHAMPVA program page and the OptumRx instruction for this request. If you also have another form of coverage, that other plan can have its own rules, but it does not replace the CHAMPVA requirements.
For the question in front of you this week, return to the same two gates. Is the obstructive sleep apnea moderate to severe, and does the sleep study fall within the past 12 months [1]? Then address the OptumRx prior authorization.
Here is the decision timeline using only the published CHAMPVA logic:
| Step | What to check | What the CHAMPVA rule says |
|---|---|---|
| Confirm the condition | Moderate to severe obstructive sleep apnea | Zepbound is listed for this condition [1] |
| Check the report date | Sleep study within the past 12 months | The condition must be verified by a sleep study within that window [1] |
| If the report is older | A 3-year-old sleep study is outside the stated window | The published facts do not list an exception or replacement document |
| Request review | OptumRx prior authorization | Call OptumRx at 844-403-1029 [1] |
| Keep the indication clear | Sleep apnea pathway, not weight loss use | CHAMPVA does not cover GLP-1 medications prescribed for weight loss [1] |
What should you do if your sleep study is 3 years old?
Start with the date, not the medication request. Find the sleep study report and confirm whether its date falls within the past 12 months. If it is 3 years old, the documented CHAMPVA rule does not place it inside the required window [1].
Next, confirm the diagnosis description you are working from. The published pathway is for moderate to severe obstructive sleep apnea, not an unspecified sleep complaint [1]. This article does not add a new documentation list because CHAMPVA's stated facts do not provide one.
Then ask about booking an updated sleep study. That is the practical action when the report you have is outside the stated 12-month window. The official rule does not say that every person with an older report must receive a new test, so the current CHAMPVA source and the clinicians involved in your care remain the place to confirm what applies to you.
Once the report date and condition are addressed, contact OptumRx at 844-403-1029 about the Zepbound prior authorization [1]. Be specific that you are asking about the CHAMPVA sleep apnea pathway. Do not describe the request as weight loss coverage, because that use is excluded by CHAMPVA [1].
If OptumRx or CHAMPVA gives you a different instruction, keep the instruction and check it against the official program page. A denial letter or written request for more information can show exactly which part of the request needs attention. No page here can promise an approval, and the official benefit source has the final word.
What to do next
Written for a CHAMPVA beneficiary deciding this week whether to book an updated sleep study:
- Locate the existing sleep study report and write down its date.
- Compare that date with the past 12-month requirement for the CHAMPVA Zepbound sleep apnea pathway [1].
- If the report is 3 years old or otherwise outside the window, ask the clinician handling your sleep apnea whether to book an updated sleep study.
- Confirm that the condition being considered is moderate to severe obstructive sleep apnea, the indication listed by CHAMPVA [1].
- Keep the current sleep study report available before calling about prior authorization.
- Call OptumRx at 844-403-1029 and request information about the CHAMPVA Zepbound prior authorization [1].
- State that the request concerns obstructive sleep apnea, not weight loss use.
- Check the CHAMPVA GLP-1 coverage guide and the CHAMPVA coverage hub against any instruction you receive.
Sources
- VA Community Care, CHAMPVA program page, Zepbound coverage for moderate to severe obstructive sleep apnea, sleep study recency, and OptumRx prior authorization, accessed 2026-08-01, https://department.va.gov/vha/community-care/family-member-care/champva/
- TRICARE, Weight Loss Products coverage page, TRICARE weight loss coverage groups and August 31, 2025 rules, accessed 2026-08-01, https://tricare.mil/weightlossproducts